Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 2.17% | $22.01M | $538.54B | 87.16% | 81 Outperform | |
| Novartis | 1.23% | $12.48M | $309.48B | 54.70% | 80 Outperform | |
| Roche Holding AG | 1.23% | $12.47M | CHF287.83B | 46.49% | 73 Outperform | |
| AstraZeneca | 0.98% | $9.88M | $319.11B | 29.06% | 80 Outperform | |
| Royal Bank Of Canada | 0.96% | $9.71M | $237.07B | 42.36% | 75 Outperform | |
| Toyota Motor | 0.72% | $7.25M | ¥49.19T | 34.78% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.69% | $7.00M | €255.60B | -26.71% | 78 Outperform | |
| Rolls-Royce Holdings | 0.68% | $6.88M | £107.13B | 117.96% | 71 Outperform | |
| Unilever | 0.65% | $6.60M | $161.26B | 20.79% | 73 Outperform | |
| ― | 0.64% | $6.44M | ― | ― | ― |